ANOBILE, DARIO PASQUALE
 Distribuzione geografica
Continente #
NA - Nord America 128
EU - Europa 60
AS - Asia 27
AF - Africa 2
OC - Oceania 1
Totale 218
Nazione #
US - Stati Uniti d'America 124
IT - Italia 36
SG - Singapore 13
IE - Irlanda 12
CN - Cina 6
MX - Messico 4
HK - Hong Kong 3
NL - Olanda 3
SE - Svezia 3
NG - Nigeria 2
VN - Vietnam 2
AL - Albania 1
AU - Australia 1
CZ - Repubblica Ceca 1
DE - Germania 1
GB - Regno Unito 1
GR - Grecia 1
IN - India 1
KR - Corea 1
RU - Federazione Russa 1
TW - Taiwan 1
Totale 218
Città #
Chandler 31
Dublin 12
Turin 8
Singapore 7
Ashburn 5
Torino 5
Ciudad Lopez Mateos 4
Milan 4
New York 4
Ann Arbor 3
Fairfield 3
Nyköping 3
Princeton 3
San Diego 3
Woodbridge 3
Abuja 2
Bari 2
Boston 2
Hangzhou 2
Hebei 2
Hong Kong 2
Medford 2
San Mauro Torinese 2
Wilmington 2
Alba 1
Andover 1
Beijing 1
Brno 1
Cambridge 1
Chengdu 1
Falls Church 1
Ferrara 1
Guishan 1
Houston 1
Kwinana 1
La Canada Flintridge 1
London 1
Los Angeles 1
Moncalieri 1
Norwalk 1
Nuremberg 1
Piemonte 1
Pune 1
San Mateo 1
Seattle 1
Seoul 1
Tirana 1
Upper Marlboro 1
Totale 140
Nome #
Evaluation of the preclinical efficacy of lurbinectedin in malignant pleural mesothelioma 71
Targeting mitochondrial oncometabolites: A new approach to overcome drug resistance in cancer 51
New Pharmacological Strategies against Pancreatic Adenocarcinoma: The Multifunctional Thiosemicarbazone FA4 46
Autocrine 17-β-estradiol/estrogen receptor-α loop determines the response to immune-checkpoint inhibitors in non-small cell lung cancer 24
Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer 23
Splicing deregulation, microRNA and notch aberrations: fighting the three-headed dog to overcome drug resistance in malignant mesothelioma 10
Totale 225
Categoria #
all - tutte 1.180
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.180


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 0 0 0 0 6
2021/202261 12 4 2 0 3 2 2 1 2 8 17 8
2022/202387 11 8 4 3 5 15 12 9 7 0 3 10
2023/202469 9 12 3 4 3 14 0 2 0 8 10 4
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 225